Published: 25 September 2026
Author(s): Francisco Javier Martín-Sánchez, Ana Suero Roiz, María Suárez Cadenas, Patricia Parra Esquivel, Begoña Espinosa, María Pilar López Díez, Rodolfo Romero Pareja, Miguel Alberto Rizzi Bordigoni, Carlos Bibiano, Javier Jacob, Enrique Martín Mojarro, Alfons Aguirre, Pere Llorens, Pablo Herrero, Esther Rodríguez Adrada, Cristina Bermejo Boixareu, Xavier Rosselló, Òscar Miró, DEED-Frail Trial Study Group
Issue: October 2026
Section: Original Article

Heart failure (HF) is a common chronic condition characterized by progressive cardiovascular and global functional decline, often punctuated by recurrent episodes of decompensation that accelerate disease progression[1] It is increasingly recognized as a geriatric syndrome associated with high mortality, frequent emergency department (ED) visits, hospital admissions, functional deterioration, institutionalization, and impaired quality of life[2] Acute decompensations, commonly referred to as acute HF (AHF) episodes, are typically managed in the ED and frequently result in hospitalization, with reported in-hospital mortality rates ranging from 5% to 10%[3–5].

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.